Global and United States Oncology Biosimilars Market Insights, Forecast to 2027

Global and United States Oncology Biosimilars Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Oncology Biosimilars Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Biosimilars Market Size Growth Rate by Type
1.2.2 Monoclonal Antibody
1.2.3 Hematopoietic Agents
1.2.4 G-CSF
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oncology Biosimilars Market Size Growth Rate by Application
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncology Biosimilars Market Size, Estimates and Forecasts
2.1.1 Global Oncology Biosimilars Revenue 2016-2027
2.1.2 Global Oncology Biosimilars Sales 2016-2027
2.2 Global Oncology Biosimilars, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Oncology Biosimilars Historical Market Size by Region (2016-2021)
2.3.1 Global Oncology Biosimilars Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Oncology Biosimilars Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Oncology Biosimilars Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Oncology Biosimilars Sales Forecast by Region (2022-2027)
2.4.2 Global Oncology Biosimilars Revenue Forecast by Region (2022-2027)
3 Global Oncology Biosimilars Competitor Landscape by Players
3.1 Global Top Oncology Biosimilars Manufacturers by Sales
3.1.1 Global Oncology Biosimilars Sales by Manufacturer (2016-2021)
3.1.2 Global Oncology Biosimilars Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Oncology Biosimilars Manufacturers by Revenue
3.2.1 Key Oncology Biosimilars Manufacturers Covered: Ranking by Revenue
3.2.2 Global Oncology Biosimilars Revenue by Manufacturers (2016-2021)
3.2.3 Global Oncology Biosimilars Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oncology Biosimilars Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Oncology Biosimilars Revenue in 2020
3.2.6 Global Oncology Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Oncology Biosimilars Price by Manufacturers
3.4 Global Oncology Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Oncology Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oncology Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into Oncology Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Oncology Biosimilars Market Size by Type (2016-2021)
4.1.1 Global Oncology Biosimilars Sales by Type (2016-2021)
4.1.2 Global Oncology Biosimilars Revenue by Type (2016-2021)
4.1.3 Oncology Biosimilars Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Oncology Biosimilars Market Size Forecast by Type (2022-2027)
4.2.1 Global Oncology Biosimilars Sales Forecast by Type (2022-2027)
4.2.2 Global Oncology Biosimilars Revenue Forecast by Type (2022-2027)
4.2.3 Oncology Biosimilars Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Oncology Biosimilars Market Size by Application (2016-2021)
5.1.1 Global Oncology Biosimilars Sales by Application (2016-2021)
5.1.2 Global Oncology Biosimilars Revenue by Application (2016-2021)
5.1.3 Oncology Biosimilars Price by Application (2016-2021)
5.2 Oncology Biosimilars Market Size Forecast by Application (2022-2027)
5.2.1 Global Oncology Biosimilars Sales Forecast by Application (2022-2027)
5.2.2 Global Oncology Biosimilars Revenue Forecast by Application (2022-2027)
5.2.3 Global Oncology Biosimilars Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Oncology Biosimilars Market Size YoY Growth 2016-2027
6.1.1 United States Oncology Biosimilars Sales YoY Growth 2016-2027
6.1.2 United States Oncology Biosimilars Revenue YoY Growth 2016-2027
6.1.3 United States Oncology Biosimilars Market Share in Global Market 2016-2027
6.2 United States Oncology Biosimilars Market Size by Players (International and Local Players)
6.2.1 United States Top Oncology Biosimilars Players by Sales (2016-2021)
6.2.2 United States Top Oncology Biosimilars Players by Revenue (2016-2021)
6.3 United States Oncology Biosimilars Historic Market Review by Type (2016-2021)
6.3.1 United States Oncology Biosimilars Sales Market Share by Type (2016-2021)
6.3.2 United States Oncology Biosimilars Revenue Market Share by Type (2016-2021)
6.3.3 United States Oncology Biosimilars Price by Type (2016-2021)
6.4 United States Oncology Biosimilars Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Oncology Biosimilars Sales Forecast by Type (2022-2027)
6.4.2 United States Oncology Biosimilars Revenue Forecast by Type (2022-2027)
6.4.3 United States Oncology Biosimilars Price Forecast by Type (2022-2027)
6.5 United States Oncology Biosimilars Historic Market Review by Application (2016-2021)
6.5.1 United States Oncology Biosimilars Sales Market Share by Application (2016-2021)
6.5.2 United States Oncology Biosimilars Revenue Market Share by Application (2016-2021)
6.5.3 United States Oncology Biosimilars Price by Application (2016-2021)
6.6 United States Oncology Biosimilars Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Oncology Biosimilars Sales Forecast by Application (2022-2027)
6.6.2 United States Oncology Biosimilars Revenue Forecast by Application (2022-2027)
6.6.3 United States Oncology Biosimilars Price Forecast by Application (2022-2027)
7 North America
7.1 North America Oncology Biosimilars Market Size YoY Growth 2016-2027
7.2 North America Oncology Biosimilars Market Facts & Figures by Country
7.2.1 North America Oncology Biosimilars Sales by Country (2016-2021)
7.2.2 North America Oncology Biosimilars Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Oncology Biosimilars Market Size YoY Growth 2016-2027
8.2 Asia Pacific Oncology Biosimilars Market Facts & Figures by Region
8.2.1 Asia Pacific Oncology Biosimilars Sales by Region (2016-2021)
8.2.2 Asia Pacific Oncology Biosimilars Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Oncology Biosimilars Market Size YoY Growth 2016-2027
9.2 Europe Oncology Biosimilars Market Facts & Figures by Country
9.2.1 Europe Oncology Biosimilars Sales by Country (2016-2021)
9.2.2 Europe Oncology Biosimilars Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Oncology Biosimilars Market Size YoY Growth 2016-2027
10.2 Latin America Oncology Biosimilars Market Facts & Figures by Country
10.2.1 Latin America Oncology Biosimilars Sales by Country (2016-2021)
10.2.2 Latin America Oncology Biosimilars Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oncology Biosimilars Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Oncology Biosimilars Market Facts & Figures by Country
11.2.1 Middle East and Africa Oncology Biosimilars Sales by Country (2016-2021)
11.2.2 Middle East and Africa Oncology Biosimilars Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Celltrion
12.1.1 Celltrion Corporation Information
12.1.2 Celltrion Description and Business Overview
12.1.3 Celltrion Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Celltrion Oncology Biosimilars Products Offered
12.1.5 Celltrion Recent Development
12.2 Biocon
12.2.1 Biocon Corporation Information
12.2.2 Biocon Description and Business Overview
12.2.3 Biocon Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Biocon Oncology Biosimilars Products Offered
12.2.5 Biocon Recent Development
12.3 Dr. Reddy's Laboratories
12.3.1 Dr. Reddy's Laboratories Corporation Information
12.3.2 Dr. Reddy's Laboratories Description and Business Overview
12.3.3 Dr. Reddy's Laboratories Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Dr. Reddy's Laboratories Oncology Biosimilars Products Offered
12.3.5 Dr. Reddy's Laboratories Recent Development
12.4 STADA Arzneimittel AG
12.4.1 STADA Arzneimittel AG Corporation Information
12.4.2 STADA Arzneimittel AG Description and Business Overview
12.4.3 STADA Arzneimittel AG Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.4.4 STADA Arzneimittel AG Oncology Biosimilars Products Offered
12.4.5 STADA Arzneimittel AG Recent Development
12.5 Intas Pharmaceuticals
12.5.1 Intas Pharmaceuticals Corporation Information
12.5.2 Intas Pharmaceuticals Description and Business Overview
12.5.3 Intas Pharmaceuticals Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Intas Pharmaceuticals Oncology Biosimilars Products Offered
12.5.5 Intas Pharmaceuticals Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Description and Business Overview
12.6.3 Pfizer Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Oncology Biosimilars Products Offered
12.6.5 Pfizer Recent Development
12.7 Sandoz International
12.7.1 Sandoz International Corporation Information
12.7.2 Sandoz International Description and Business Overview
12.7.3 Sandoz International Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sandoz International Oncology Biosimilars Products Offered
12.7.5 Sandoz International Recent Development
12.8 Teva Pharmaceutical Industries Ltd
12.8.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.8.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
12.8.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Products Offered
12.8.5 Teva Pharmaceutical Industries Ltd Recent Development
12.9 Apotex
12.9.1 Apotex Corporation Information
12.9.2 Apotex Description and Business Overview
12.9.3 Apotex Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Apotex Oncology Biosimilars Products Offered
12.9.5 Apotex Recent Development
12.10 BIOCAD
12.10.1 BIOCAD Corporation Information
12.10.2 BIOCAD Description and Business Overview
12.10.3 BIOCAD Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.10.4 BIOCAD Oncology Biosimilars Products Offered
12.10.5 BIOCAD Recent Development
12.11 Celltrion
12.11.1 Celltrion Corporation Information
12.11.2 Celltrion Description and Business Overview
12.11.3 Celltrion Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Celltrion Oncology Biosimilars Products Offered
12.11.5 Celltrion Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Oncology Biosimilars Industry Trends
13.2 Oncology Biosimilars Market Drivers
13.3 Oncology Biosimilars Market Challenges
13.4 Oncology Biosimilars Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oncology Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Oncology Biosimilars Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibody
Table 3. Major Manufacturers of Hematopoietic Agents
Table 4. Major Manufacturers of G-CSF
Table 5. Major Manufacturers of Others
Table 6. Global Oncology Biosimilars Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Oncology Biosimilars Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Oncology Biosimilars Sales by Regions (2016-2021) & (K Units)
Table 9. Global Oncology Biosimilars Sales Market Share by Regions (2016-2021)
Table 10. Global Oncology Biosimilars Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Oncology Biosimilars Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Oncology Biosimilars Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Oncology Biosimilars Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Oncology Biosimilars Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Oncology Biosimilars Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Oncology Biosimilars Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Oncology Biosimilars Manufacturers by Revenue (US$ Million) in 2020
Table 18. Oncology Biosimilars Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Oncology Biosimilars Revenue Share by Manufacturers (2016-2021)
Table 20. Global Oncology Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Oncology Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Biosimilars as of 2020)
Table 22. Key Manufacturers Oncology Biosimilars Price (2016-2021) (US$/Unit)
Table 23. Oncology Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Oncology Biosimilars Product Type
Table 25. Date of International Manufacturers Enter into Oncology Biosimilars Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Oncology Biosimilars Sales by Type (2016-2021) (K Units)
Table 28. Global Oncology Biosimilars Sales Share by Type (2016-2021)
Table 29. Global Oncology Biosimilars Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Oncology Biosimilars Revenue Share by Type (2016-2021)
Table 31. Oncology Biosimilars Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 32. Global Oncology Biosimilars Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Oncology Biosimilars Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Oncology Biosimilars Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Oncology Biosimilars Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Oncology Biosimilars Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Oncology Biosimilars Sales by Application (2016-2021) (K Units)
Table 38. Global Oncology Biosimilars Sales Share by Application (2016-2021)
Table 39. Global Oncology Biosimilars Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Oncology Biosimilars Revenue Share by Application (2016-2021)
Table 41. Oncology Biosimilars Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 42. Global Oncology Biosimilars Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Oncology Biosimilars Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Oncology Biosimilars Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Oncology Biosimilars Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Oncology Biosimilars Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 47. United States Oncology Biosimilars Sales (K Units) of Key Companies (2016-2021)
Table 48. United States Oncology Biosimilars Sales Share by Company (2016-2021)
Table 49. United States Oncology Biosimilars Revenue (US$ Million) by Company (2016-2021)
Table 50. United States Oncology Biosimilars Revenue Share by Company (2016-2021)
Table 51. United States Oncology Biosimilars Sales (K Units) by Type (2016-2021)
Table 52. United States Oncology Biosimilars Sales Share by Type (2016-2021)
Table 53. United States Oncology Biosimilars Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States Oncology Biosimilars Price (US$/Unit) by Type (2016-2021)
Table 55. United States Oncology Biosimilars Sales (K Units) by Type (2022-2027)
Table 56. United States Oncology Biosimilars Sales Share by Type (2022-2027)
Table 57. United States Oncology Biosimilars Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States Oncology Biosimilars Revenue Share by Type (2022-2027)
Table 59. United States Oncology Biosimilars Price (US$/Unit) by Type (2022-2027)
Table 60. United States Oncology Biosimilars Sales (K Units) by Application (2016-2021)
Table 61. United States Oncology Biosimilars Sales Share by Application (2016-2021)
Table 62. United States Oncology Biosimilars Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. United States Oncology Biosimilars Price (US$/Unit) by Application (2016-2021)
Table 64. United States Oncology Biosimilars Sales (K Units) by Application (2022-2027)
Table 65. United States Oncology Biosimilars Sales Share by Application (2022-2027)
Table 66. United States Oncology Biosimilars Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. United States Oncology Biosimilars Revenue Share by Application (2022-2027)
Table 68. United States Oncology Biosimilars Price (US$/Unit) by Application (2022-2027)
Table 69. North America Oncology Biosimilars Sales by Country (2016-2021) & (K Units)
Table 70. North America Oncology Biosimilars Sales Market Share by Country (2016-2021)
Table 71. North America Oncology Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Oncology Biosimilars Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Oncology Biosimilars Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Oncology Biosimilars Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Oncology Biosimilars Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Oncology Biosimilars Revenue Market Share by Region (2016-2021)
Table 77. Europe Oncology Biosimilars Sales by Country (2016-2021) & (K Units)
Table 78. Europe Oncology Biosimilars Sales Market Share by Country (2016-2021)
Table 79. Europe Oncology Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Oncology Biosimilars Revenue Market Share by Country (2016-2021)
Table 81. Latin America Oncology Biosimilars Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Oncology Biosimilars Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Oncology Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Oncology Biosimilars Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Oncology Biosimilars Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Oncology Biosimilars Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Oncology Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Oncology Biosimilars Revenue Market Share by Country (2016-2021)
Table 89. Celltrion Corporation Information
Table 90. Celltrion Description and Business Overview
Table 91. Celltrion Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 92. Celltrion Oncology Biosimilars Product
Table 93. Celltrion Recent Development
Table 94. Biocon Corporation Information
Table 95. Biocon Description and Business Overview
Table 96. Biocon Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 97. Biocon Product
Table 98. Biocon Recent Development
Table 99. Dr. Reddy's Laboratories Corporation Information
Table 100. Dr. Reddy's Laboratories Description and Business Overview
Table 101. Dr. Reddy's Laboratories Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 102. Dr. Reddy's Laboratories Product
Table 103. Dr. Reddy's Laboratories Recent Development
Table 104. STADA Arzneimittel AG Corporation Information
Table 105. STADA Arzneimittel AG Description and Business Overview
Table 106. STADA Arzneimittel AG Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 107. STADA Arzneimittel AG Product
Table 108. STADA Arzneimittel AG Recent Development
Table 109. Intas Pharmaceuticals Corporation Information
Table 110. Intas Pharmaceuticals Description and Business Overview
Table 111. Intas Pharmaceuticals Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 112. Intas Pharmaceuticals Product
Table 113. Intas Pharmaceuticals Recent Development
Table 114. Pfizer Corporation Information
Table 115. Pfizer Description and Business Overview
Table 116. Pfizer Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 117. Pfizer Product
Table 118. Pfizer Recent Development
Table 119. Sandoz International Corporation Information
Table 120. Sandoz International Description and Business Overview
Table 121. Sandoz International Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 122. Sandoz International Product
Table 123. Sandoz International Recent Development
Table 124. Teva Pharmaceutical Industries Ltd Corporation Information
Table 125. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 126. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 127. Teva Pharmaceutical Industries Ltd Product
Table 128. Teva Pharmaceutical Industries Ltd Recent Development
Table 129. Apotex Corporation Information
Table 130. Apotex Description and Business Overview
Table 131. Apotex Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 132. Apotex Product
Table 133. Apotex Recent Development
Table 134. BIOCAD Corporation Information
Table 135. BIOCAD Description and Business Overview
Table 136. BIOCAD Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 137. BIOCAD Product
Table 138. BIOCAD Recent Development
Table 139. Oncology Biosimilars Market Trends
Table 140. Oncology Biosimilars Market Drivers
Table 141. Oncology Biosimilars Market Challenges
Table 142. Oncology Biosimilars Market Restraints
Table 143. Oncology Biosimilars Customers List
Table 144. Oncology Biosimilars Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Biosimilars Product Picture
Figure 2. Global Oncology Biosimilars Sales Market Share by Type in 2020 & 2027
Figure 3. Monoclonal Antibody Product Picture
Figure 4. Hematopoietic Agents Product Picture
Figure 5. G-CSF Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oncology Biosimilars Sales Market Share by Application in 2020 & 2027
Figure 8. Retail Pharmacies
Figure 9. Hospital Pharmacy
Figure 10. Online Pharmacy
Figure 11. Oncology Biosimilars Report Years Considered
Figure 12. Global Oncology Biosimilars Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Oncology Biosimilars Market Size 2016-2027 (US$ Million)
Figure 14. Global Oncology Biosimilars Sales 2016-2027 (K Units)
Figure 15. Global Oncology Biosimilars Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Oncology Biosimilars Sales Market Share by Region (2016-2021)
Figure 17. Global Oncology Biosimilars Sales Market Share by Region in 2020
Figure 18. Global Oncology Biosimilars Revenue Market Share by Region (2016-2021)
Figure 19. Global Oncology Biosimilars Revenue Market Share by Region in 2020
Figure 20. Global Oncology Biosimilars Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Oncology Biosimilars Revenue in 2020
Figure 22. Oncology Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Oncology Biosimilars Sales Market Share by Type (2016-2021)
Figure 24. Global Oncology Biosimilars Sales Market Share by Type in 2020
Figure 25. Global Oncology Biosimilars Revenue Market Share by Type (2016-2021)
Figure 26. Global Oncology Biosimilars Revenue Market Share by Type in 2020
Figure 27. Global Oncology Biosimilars Sales Market Share by Application (2016-2021)
Figure 28. Global Oncology Biosimilars Sales Market Share by Application in 2020
Figure 29. Global Oncology Biosimilars Revenue Market Share by Application (2016-2021)
Figure 30. Global Oncology Biosimilars Revenue Market Share by Application in 2020
Figure 31. United States Oncology Biosimilars Sales Growth Rate 2016-2027 (K Units)
Figure 32. United States Oncology Biosimilars Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. United States Oncology Biosimilars Market Share in Global Market 2016-2027
Figure 34. United States 5 and 10 Largest Oncology Biosimilars Players Market Share by Revenue in Oncology Biosimilars in 2020
Figure 35. United States Oncology Biosimilars Revenue Share by Type (2016-2021)
Figure 36. United States Oncology Biosimilars Revenue Growth Rate by Type in 2016 & 2020
Figure 37. United States Oncology Biosimilars Revenue Share by Application (2016-2021)
Figure 38. United States Oncology Biosimilars Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Oncology Biosimilars Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Oncology Biosimilars Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Oncology Biosimilars Sales Market Share by Country in 2020
Figure 42. North America Oncology Biosimilars Revenue Market Share by Country in 2020
Figure 43. U.S. Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 44. U.S. Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Oncology Biosimilars Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe Oncology Biosimilars Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Oncology Biosimilars Sales Market Share by Country in 2020
Figure 50. Europe Oncology Biosimilars Revenue Market Share by Country in 2020
Figure 51. Germany Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 54. France Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 56. U.K. Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 60. Russia Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Oncology Biosimilars Sales Growth Rate 2016-2021 (K Units)
Figure 62. Asia Pacific Oncology Biosimilars Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Oncology Biosimilars Sales Market Share by Region in 2020
Figure 64. Asia Pacific Oncology Biosimilars Revenue Market Share by Region in 2020
Figure 65. China Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 66. China Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 68. Japan Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 70. South Korea Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 72. India Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 74. Australia Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 76. Taiwan Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 78. Indonesia Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 80. Thailand Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 82. Malaysia Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 84. Philippines Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Oncology Biosimilars Sales Growth Rate (2016-2021) (K Units)
Figure 86. Vietnam Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Oncology Biosimilars Sales Growth Rate 2016-2021 (K Units)
Figure 88. Latin America Oncology Biosimilars Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Oncology Biosimilars Sales Market Share by Country in 2020
Figure 90. Latin America Oncology Biosimilars Revenue M

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs